Bernard Prendergast, ESC 2018 – MITRA-FR, MitraClip and Mitral Valve Regurgitation
Professor Bernard Prendergast (Consultant Cardiologist, London Bridge Hospital, London, UK) discusses percutaneous mitral valve repair and mitral valve regurgitation, with particular emphasis on the results of the MITRA-FR trial and the MitraClip device.
Filmed at ESC 2018, Munich.
View more content here.
Speaker Disclosure: Professor Bernard Prendergast has nothing to disclose in relation to this video interview.
Questions:
1. What are the potential advantages and disadvantages of percutaneous mitral valve repair with MitraClip over optimal medical therapy for mitral valve regurgitation? (0:08)
2. What features of the MITRA-FR trial represent an improvement over previous studies assessing percutaneous mitral valve repair as a therapeutic option for mitral valve regurgitation? (1:00)
3. Please summarise the key results of the MITRA-FR trial? (2:02)
4. How do you determine which patients may be suitable for MitraClip? (2:59)
5. What are the short- and long-term goals for the treatment of mitral valve regurgitation? (3:41)
6. How was the study designed? (4:32)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.